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Abstract The circadian pacemaker is an endogenous clock that regulates oscilla-
tions in most physiological and psychological processes with a near 24-h period.
In many species, this pacemaker triggers seasonal changes in behavior. The sea-
sonality of symptoms and the efficacy of light therapy suggest involvement of
the circadian pacemaker in seasonal affective disorder (SAD), winter type. In this
study, circadian pacemaker characteristics of SAD patients were compared with
those of controls. Seven SAD patients and matched controls were subjected to a
120-h forced desynchrony protocol, in which core body temperature and
melatonin secretion profiles were measured for the characterization of circadian
pacemaker parameters. During this protocol, which enables the study of
unmasked circadian pacemaker characteristics, subjects were exposed to six 20-h
days in time isolation. Patients participated twice in winter (while depressed and
while remitted after light therapy) and once in summer. Controls participated
once in winter and once in summer. Between the SAD patients and controls, no
significant differences were observed in the melatonin-derived period or in the
phase of the endogenous circadian temperature rhythm. The amplitude of this
rhythm was significantly smaller in depressed and remitted SAD patients than in
controls. No abnormalities of the circadian pacemaker were observed in SAD
patients. A disturbance in thermoregulatory processes might explain the smaller
circadian temperature amplitude in SAD patients during winter.
Key words seasonal affective disorder, circadian pacemaker, circadian rhythms, core body
temperature, melatonin, forced desynchrony
The remarkable seasonal fluctuation of mood and
the efficacy of bright-light therapy in patients with
seasonal affective disorder (SAD), winter type, have
suggested involvement of the circadian pacemaker in
the pathogenesis of this disorder. The present study is
devoted to the search for possible circadian abnormal-
ities in SAD patients.
The circadian pacemaker is localized in the
suprachiasmatic nucleus (SCN) of the brain and oper-
ates as an endogenous timekeeping mechanism (Van
Esseveldt et al., 2000). This pacemaker generates oscil-
lations in many physiological and psychological pro-
cesses (Aschoff, 1965) with a near 24-h period
(Hiddinga et al., 1997; Carskadon et al., 1999; Czeisler
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et al., 1999). By its sensitivity to light, the circadian
pacemaker is able to respond to seasonal changes in
day length, or photoperiod. Throughout the day, reti-
nal light exposure synchronizes this biological clock
with the environmental light:dark cycle (Honma and
Honma, 1988; Minors et al., 1991; Boivin et al., 1996;
Jewett et al., 1997).
In human circadian pacemaker research, the varia-
tions of body temperature and of melatonin secretion
are often used to study pacemaker output. However,
despite the relative ease with which these variables
can be measured, the interpretation of these measures
in terms of circadian output is complicated by several
masking factors. For instance, the nightly secretion of
melatonin, which is dependent on the timing and
duration of the photoperiod (Lewy et al., 1985), can be
directly suppressed by light exposure (Lewy et al.,
1980). Therefore, the most accurate estimates of circa-
dian pacemaker characteristics derived from the
melatonin secretion profile are obtained in dim light.
The endogenous circadian variation of body tempera-
ture, in turn, is modulated by the effects of activity,
meals, and sleep. The circadian component in temper-
ature data can be obtained by experimentally control-
ling for masking factors in a constant routine—or a
forced desynchrony (FD) protocol. In a constant rou-
tine procedure, masking factors are kept constant by
keeping subjects in a supine posture and feeding them
frequent small meals and exposing them to a pro-
longed period of wakefulness (Mills et al., 1978;
Czeisler et al., 1985). However, the sleep deprivation
induced by the constant routine procedure elicits a
worsening of mood in healthy subjects (Brendel et al.,
1990) and an improvement of mood in depressed
patients (Graw et al., 1998). Therefore, this procedure
has limitations for studies in which mood regulation is
examined. The FD protocol is more suitable because it
enables control over the relevant masking factors
without eliminating them, while sleep deprivation
effects are avoided. During FD, participants are sub-
jected to a sleep-wake cycle that is shorter or longer
than 24 h (i.e., either 20 h or 28 h). The subjective days
are spent in dim light (< 10 lux) and have a fixed tem-
poral structure. The circadian pacemaker is not able to
adapt to this unusual alternation of wakefulness and
sleep and starts to oscillate with its own endogenous
period. Consequently, the pacemaker and the sleep-
wake cycle desynchronize (Kleitman and Kleitman,
1953; Czeisler et al., 1986; Dijk et al., 1992). Assuming
that circadian and masking factors contribute
additively to the overt rhythms measured, a mathe-
matical procedure enables the distinction between
these two contributors to the measurements
(Hiddinga et al., 1997; Czeisler et al., 1999) without the
need for prolonged sleep deprivation. Therefore, the
method of FD was used in the present study.
CIRCADIAN RHYTHM STUDIES IN SAD
The hypotheses concerning the involvement of the
circadian pacemaker in SAD have mainly focused on
circadian phase and amplitude. It has been postulated
that in SAD, the circadian pacemaker is phase-shifted
relative to the timing of the habitual sleep-wake cycle
(in most patients, the pacemaker is phase-delayed)
and that the phase-advancing properties of morning
light account for the efficacy of light treatment (Lewy,
Sack, Singer, et al., 1987). Alternatively, a diminished
circadian amplitude has been hypothesized to be
involved in the pathogenesis of SAD. According to
this hypothesis, amplitude-enhancing effects of light
applied in daytime might explain the beneficial effects
of light treatment in SAD (Czeisler et al., 1987).
The majority of studies addressing the circadian
hypotheses in SAD are naturalistic (i.e., carried out
under normal sleep timing), which means that mask-
ing effects could be involved. Therefore, the results of
these studies at times provide limited information
about the circadian pacemaker. A few studies
addressed the issue with a constant routine protocol.
NATURALISTIC STUDIES IN SAD
Several studies have been published in which the
melatonin secretion patterns of SAD patients in dim
light are compared to those found in controls.
Melatonin secretion patterns are studied because they
are largely controlled by the circadian pacemaker and
are relatively insensitive to most kinds of masking
influences. Some of these revealed a delay in dim-light
melatonin onset (DLMO) (i.e., time at which a crite-
rion level of melatonin concentration is reached) in
SAD patients (Lewy, Sack, Miller, et al., 1987; Sack
et al., 1990; Lewy et al., 1998), whereas others did not
(Checkley et al., 1993; Thompson et al., 1997). Phase-
advance shifts of DLMO have been reported after
morning-light therapy and phase-delay shifts after
evening-light therapy in both patients (Lewy, Sack,
Miller, et al., 1987; Lewy et al., 1998; Terman et al.,
2001) and controls (Lewy, Sack, Miller, et al., 1987;
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Lewy et al., 1998). However, in two studies a phase
advance of DLMO after morning-light therapy was
observed in patients only (Sack et al., 1990; Thompson
et al., 1997). Studies in which entire melatonin secre-
tion profiles were reported demonstrated similar
amounts of melatonin production and amplitudes in
patients before (Checkley et al., 1993; Thompson et al.,
1997) and after (Thompson et al., 1997) light therapy.
Likewise, a similar total melatonin production was
found in patients before and after morning- or evening-
light therapy (Terman et al., 2001). Comparisons of
temperature data have demonstrated no differences in
circadian temperature parameters between SAD
patients and controls in both winter (Rosenthal et al.,
1990; Eastman et al., 1993; Schwartz et al., 1997) and
summer (Levendosky et al., 1991; Schwartz et al.,
1997). The mean level of body temperature was signif-
icantly lower in summer than in winter in both
patients and controls in one of these studies
(Levendosky et al., 1991), whereas another study
revealed a significant lowering of the nocturnal body
temperature in summer in patients only (Schwartz
et al., 1997). Following light therapy, an increase in
amplitude of the circadian temperature profile has
been found when patients received a combination of
morning and evening light (Rosenthal et al., 1990).
However, in a morning-light therapy study, it was
observed that the circadian temperature amplitude of
patients and controls remained unaffected (Eastman
et al., 1993). Both groups showed similar phase-
shifting responses.
CONSTANT ROUTINE STUDIES IN SAD
In the two constant routine studies done so far, last-
ing 27 and 40 h, respectively, DLMO and the circadian
rhythms in core body temperature were measured in
female SAD patients and controls (Dahl et al., 1993;
Wirz-Justice et al., 1995). From all investigated circa-
dian parameters in the 40-h study, only the midrange
crossing of the rising morning limb of the temperature
curve showed a delayed phase position of patients rel-
ative to controls. Midday light therapy did not change
salivary melatonin parameters but resulted in phase
advances of some aspects of the temperature curves in
patients only (Wirz-Justice et al., 1995). In the 27-h con-
stant routine study, DLMO and the circadian rhythm
in core body temperature were measured (Dahl et al.,
1993). DLMO and the circadian temperature mini-
mum were significantly phase-delayed in patients in
comparison to those in controls. Patients showed an
advance after morning-light therapy. In both studies,
no differences in the amplitude of the melatonin secre-
tion patterns and of the body temperature curves were
observed between patients and controls, nor did the
amplitudes change significantly in response to treat-
ment. Constant routine protocols have the disadvan-
tage that they entail sleep deprivation and therefore
potentially yield a change of mood. Indeed, visual
analogue scale data on mood revealed an antidepres-
sant effect during the 40-h constant routine study
(Wirz-Justice et al., 1995). No changes of mood were
found in the 27-h constant routine experiment, but
after finishing the protocol, some subjects experienced
improvement (Avery et al., 1997).
In conclusion, the data do not yield a consistent pic-
ture of the circadian system in SAD patients. The rea-
sons for the lack of consistency probably are small
sample sizes and that masking factors could not be
avoided in those studies. An alternative way to exam-
ine the circadian system is to apply an FD protocol. To
the best of our knowledge, the present study is the first
in which this was done in SAD patients.
METHODS AND MATERIALS
Recruitment and Selection Criteria
SAD patients of our outpatient clinic, who were
known to be good responders to light therapy in pre-
vious years, received written general information on
the study. Healthy controls were recruited by adver-
tisements in local newspapers and on local television.
Subjects who were interested first received a detailed
description of the study by letter and were then
invited for a screening procedure if they considered
participation. Patients were diagnosed according to
the DSM-IV criteria for recurrent major depression
with seasonal pattern (American Psychiatric Associa-
tion, 1994) and had to meet the Rosenthal criteria for
SAD (Rosenthal et al., 1984). Controls had to have no
psychological complaints or sleeping problems. To
evaluate general psychological health, depressed
mood, seasonality, and morningness/eveningness,
both patients and healthy subjects completed a num-
ber of questionnaires: the Beck Depression Inventory
(BDI) (Beck et al., 1979); the Structured Interview
Guide for the Hamilton Depression Rating Scale–
Seasonal Affective Disorder–Self-Rating version
(SIGH-SAD-SR) (Williams et al., 1992), consisting of
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the 21-item Hamilton Depression Rating Scale
(HDRS) and an 8-item Atypical Symptom Scale
(ATYP); the General Health Questionnaire (GHQ)
(Goldberg and Williams, 1988); the Seasonal Personal-
ity Assessment Questionnaire (SPAQ) (Rosenthal et al.,
1987); and the Morningness-Eveningness (M-E) ques-
tionnaire (Horne and Ostberg, 1976). Criteria for par-
ticipation as a control subject were a BDI score < 9, a
SIGH-SAD-SR score < 8, a GHQ score < 3, and a SPAQ
score < 8 (Kasper et al., 1989). All subjects were exam-
ined by a physician and were declared physically fit.
In women, the menstrual cycle was assessed through
self-report. With the exception of oral contraceptive
pills and nonsteroidal anti-inflammatory drugs
(NSAIDs), neither patients nor controls used any
medication at least 1 month prior to the experiment.
Nobody was dependent on alcohol or caffeine. During
6 months before the study, SAD patients did not use
psychoactive drugs. After a verbal explanation of the
main characteristics of the protocol, subjects gave
written informed consent. The study was approved by
the Medical Ethics Committee of the Groningen Aca-
demic Hospital. Patients and controls were matched
for age, sex, phase of the menstrual cycle, and smok-
ing habits. SAD patients were engaged in the study
once during a depressive episode, once when remitted
after light therapy, and once in summer. Controls par-
ticipated once in winter and once in summer. Both
patients and controls were paid for their participation.
During the winter season, BDI and SIGH-SAD-SR
ratings were obtained weekly from SAD patients. Par-
ticipation during a depressive episode required a BDI
score≥ 16. Light therapy thereafter consisted of 45 min
of bright light once a day with an intensity of 10,000
lux for 5 consecutive days. After recovery, a BDI score
< 6 was required for participation in the next step in
the project. A consequence of the selection procedure
was that all patients were studied for the first time
when they were depressed. In contrast, 6 of 8 control
subjects were first studied in summer. If appropriate,
female patients were studied in the follicular phase of
their menstrual cycle.
Subjects
From November 1997 until December 1999, 7 SAD
patients (1 man and 6 women) and 8 control subjects
(1 man and 7 women) were studied. Table 1 lists the
respective scores (mean ± SD) of patients and controls
on the GHQ, SPAQ, and M-E questionnaire completed
at the introduction meeting. For the winter studies,
subjects entered the time isolation unit in the months
October through March. The summer studies started
in May and ended in August. One female control sub-
ject dropped out after finishing the protocol in sum-
mer and was replaced by another matched control for
the winter experiment. Three patients and 3 controls
smoked cigarettes.
Of the female patients, 1 had a regular natural men-
strual cycle, 3 used combined oral contraceptives,
1 used a depot progesterone, and 1 was post-
menopausal and used hormone replacement therapy
during the winter. Consequently, 4 female patients
could consistently be studied in the (pseudo-)
follicular phase and 1 in the pseudoluteal phase of the
menstrual cycle. The postmenopausal patient was
studied in the pseudoluteal phase while depressed
and in the pseudofollicular phase while remitted. Of
the female controls, 2 had a regular natural menstrual
cycle, 3 used combined oral contraceptives, and 2
were postmenopausal (one used estrogen replace-
ment therapy). Except for the winter condition of the
control subject who was matched with the
postmenopausal patient, the times of participation of
female controls were carefully matched for menstrual
cycle phase. The mean baseline scores on the BDI,
SIGH-SAD-SR, HDRS, and ATYP are summarized for
each condition in Table 1. During their stay in the time
isolation unit, 4 patients used NSAIDs (paracetamol):
2 while depressed (1 and 4 × 500 mg, respectively),
1 while remitted (3× 500 mg), and 1 in summer (1× 500
mg).
Design of the Protocol
In each condition, patients and controls were sub-
jected to a 10-day protocol. During the first 4 days,
subjects adhered to a regular sleep-wake schedule at
home. Adherence was verified by actimetry. The
actimeter was worn continuously on the non-
dominant arm and was connected to a portable
recorder (Bakker and Beersma, 1991). Sleep was
scheduled from midnight till 0800. Subjects limited
their coffee consumption to four cups a day and
abstained from alcoholic beverages, heavy physical
exercise, and daytime naps.
On day 4 at 1800, subjects entered the time isolation
unit located in the Department of Psychiatry at
Groningen Academic Hospital. The unit is shielded
from all possible information on time of day. It com-
prises a small living room with a bed and a bathroom.
After a period of familiarizing with the standard pro-
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cedures during wake time and a habituation night, the
120-h FD protocol started on day 5 at 0800. Subjects
were blind to the experimental time schedule. The
schedule consisted of six 20-h days. These artificial
20-h days were subdivided into epochs of 13.5 h of
wakefulness in dim light (< 10 lux) and 6.5 h of dark-
ness in which the subjects had to stay in bed. Each 20-h
day had the same temporal structure. Staff members
who were trained to communicate no information on
time of day, announced the moments of rising, show-
ering, meals, completing psychometric test batteries,
and going to bed. Besides the scheduled activities,
subjects could engage in all kinds of activities such as
watching videos, listening to music, and so on. Amax-
imum of four caffeine-containing drinks was allowed
only during the subjective morning. On average, sub-
jects consumed 2.6 caffeinated beverages per day of
the protocol. There was no significant effect of time in
study or between experimental conditions. Through-
out their stay in the time isolation unit, subjects were
continuously observed through an infrared television
camera.
Melatonin
On days 4 and 9 of the protocol, from 1700 until
midnight and from 1700 until 0200, respectively, saliva
was sampled hourly for the determination of
melatonin concentration. In two patients, saliva was
collected in small plastic containers. In all other sub-
jects, it was sampled by means of Salivettes (Sarstedt,
Nümbrecht, Germany) with a cotton swab. Subjects
were asked to remain seated during the 15 min prior to
the saliva collection. All samples were frozen at ≤ –18
°C immediately afterward. After each saliva sample,
eating (with the exception of chocolate and bananas),
drinking, and smoking were allowed for 15 min. Then,
subjects thoroughly rinsed their mouth with water.
Melatonin concentrations were measured by
means of radioimmunoassay (Bühlmann, Allschwil,
Switzerland), which was performed at the laboratory
of the hospital De Gelderse Vallei in Bennekom, the
Netherlands. In this laboratory, the following assay
parameters were obtained: a limit of detection of 0.5
pg/mL, an intra-assay variation of covariance of
8.78% (mean melatonin concentration 8.65 pg/mL, n =
26), and an interassay variation of covariance in sam-
ples with a low melatonin concentration of 9.6%
(mean 1.98 pg/mL, n = 30) and in samples with a high
concentration of 9.8% (mean 14.76 pg/mL, n = 30). For
each experiment, melatonin values were expressed as
a percentage of the maximum value observed on day 4.
DLMO was defined as the time at which the normal-
ized melatonin curve crossed the 25% level. Because
the body temperature recordings confirmed that five
circadian cycles had passed between the two DLMOs,
an estimate of the circadian rhythm period (τ) could be
obtained by dividing the epoch between the two
DLMOs by five.
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Table 1. Characteristics (mean ± SD) of seasonal affective disorder patients and controls
Patients Controls
Agea 36.3 ± 13.9 38.1 ± 12.8
GHQ 1.4 ± 2.3 0.3 ± 0.5
SPAQb 16.7 ± 3.6 3.5 ± 1.8
M-Ec 44.7 ± 10.4 51.4 ± 13.7
Depressed Remitted Summer Winter Summer
Mood Scores at Baseline (n = 7) (n = 7) (n = 7) (n = 7) (n = 7)
BDId 20.3 ± 6.1 1.7 ± 1.8 0.6 ± 0.8 0.3 ± 0.8 0.3 ± 0.5
SIGH-SAD-SRd 32.3 ± 11.8 3.7 ± 4.3 1.1 ± 1.9 1.4 ± 2.1 1.6 ± 1.6
21-item HDRSd 21.3 ± 7.9 2.0 ± 2.0 0.9 ± 1.5 0.9 ± 0.9 1.3 ± 1.5
ATYPd 11.0 ± 5.4 1.7 ± 2.2 0.3 ± 0.5 0.6 ± 1.5 0.3 ± 0.8
NOTE: GHQ = General Health Questionnaire, SPAQ = Seasonal Personality Assessment Questionnaire, M-E = Morningness-Eveningness
questionnaire, BDI = Beck Depression Inventory, SIGH-SAD-SR = Structured Interview Guide for the Hamilton Depression Rating Scale–
Seasonal Affective Disorder–Self-Rating version, HDRS = Hamilton Depression Rating Scale, ATYP = Atypical Symptom Scale.
a. Age at the start of the first experiment.
b. M-E scores < 30 and > 70 correspond with evening and morning types, respectively (Horne and Ostberg, 1976).
c. Patients differed significantly from controls (t test, p = 0.000).
d. An analysis of variance yielded p < 0.05. Depressed patients differed significantly from all other groups; there were no significant differences
between other groups.
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Core Body Temperature
Throughout the entire stay in the time isolation
unit, core body temperature was measured continu-
ously with a calibrated rectal thermometer (Yellow
Springs Instrument Company, Yellow Springs, OH,
USA). The data were stored at 1-min intervals by a
portable recorder (Bakker and Beersma, 1991). Those
parts of the temperature curve that were considered
unreliable due to technical failures were not used for
further analysis. Intervals of missing data shorter than
1.5 h in duration were linearly interpolated, and inter-
vals longer than 1.5 h were regarded as missing data.
To identify the endogenous circadian temperature
curve, the following mathematical procedure was
used. It is based on the assumption that the raw tem-
perature data obtained during the 120-h FD protocol
represent the sum of the exogenous sleep-wake–
induced curve and the endogenous circadian curve.
First, the raw data of the 6 consecutive 20-h subjective
days were averaged to obtain an estimation of the
mean sleep-wake–related course of body tempera-
ture. With this procedure, the circadian contribution
to the raw temperature data is roughly averaged out,
as each subjective 20-h day has the same temporal
structure and all scheduled activities occur at all circa-
dian phases. To obtain an estimation of the endoge-
nous circadian temperature curve, the obtained mean
sleep-wake–related temperature curve was sub-
tracted from the raw curve. Subsequently, the result-
ing curve was divided into epochs with the length of
the melatonin-derived τ value and then averaged
(starting from 0800 on day 4 of the protocol). Due to
the fact that the melatonin-derived τ values differ
from 24 h, the pacemaker-related contribution was not
averaged out completely during the first step of the
mathematical procedure. To establish a better estima-
tion of the sleep-wake–related contribution to the tem-
perature curve, the obtained average circadian tem-
perature curve was subtracted from the original raw
data. The resulting curve was again divided into 20-h
epochs and averaged, and so on. This procedure was
repeated until a stable estimation of the circadian tem-
perature curve was obtained (see Hiddinga et al.,
1997). On the basis of that endogenous component, the
timing of the minimum on the first day in the FD pro-
tocol was determined as a measure of baseline phase.
For that purpose, the endogenous component was
extrapolated backward to the first day of the protocol.
The clock time was determined of the midpoint
between the upward and downward crossings
through the average value of the temperature by
means of a 1-h moving average procedure. A measure
of amplitude was obtained for the sleep-wake–
induced variation and for the pacemaker-induced
variation of body temperature. For the sleep-wake-
induced variation, this was done by computing the
standard deviation of the data of the last 6.5 h of wake-
fulness and the 6.5 h allowed for sleep. In this way, the
influence of showering on the amplitude is excluded.
As a measure of amplitude of the circadian pace-
maker–related variation, the standard deviation of all
data within one cycle of the pacemaker-induced tem-
perature variation curve is calculated.
Polysomnography
From each subjective night, a polysomnographical
(PSG) recording was obtained. Location of electrodes
and scoring criteria were according to the standards
defined by Rechtschaffen and Kales (1968). The PSG
recordings were scored in 30-sec intervals with the aid
of VitaPort software (TEMEC Instruments, Kerkrade,
the Netherlands) by three raters. The average agree-
ment between raters was 95.4% (range: 94.1% to
96.3%), with an average largest disagreement interval
of 3 min (range: 1.5 to 4 min). Total sleep time (TST) per
sleeping period was calculated by adding the total
amount of minutes in sleep stages 1, 2, 3, 4, and REM.
Statistical Procedures
Power analyses were performed to estimate the
smallest detectable differences by calculating δ from
the formula n ≥ 2(σ/δ)2{tα[v] + t2(1 – P)[v]}2, with a power P
= 0.80. In this formula, n represents the number of rep-
lications, σ the true standard deviation, δ the smallest
desired difference to detect,α the level of significance,
P the intended power of the test, v the degrees of free-
dom (v = a(n – 1)), and a the number of populations;
t0.05[12] = 2.179 and t0.4[12] = 0.873 (Sokal and Rohlf, 1981).
The data derived from melatonin and temperature
recordings were analyzed statistically by means of
paired-samples tests. Analysis of variance (ANOVA)
with repeated measures was applied to evaluate TST.
The Spearman correlation coefficient was computed
to evaluate the association between the average level
of core body temperature and the amplitude of the
observed circadian temperature component. The
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analyses were two-tailed, and statistical significance
was established at p < 0.05. With this procedure, no
correction is applied to account for multiple testing.
RESULTS
The Circadian Period, ,
Based on Melatonin Data
In each condition, melatonin concentrations
showed a gradual increase. As mentioned earlier,
DLMO was defined as the time at which melatonin
production reached 25% of the maximal production
on day 4. In 2 of the remitted patients, the initial
melatonin production in the second sampling period
(day 9) exceeded this 25% criterion. Therefore, in these
subjects the criterion was raised to 50%. The exact
choice of the criterion level has little influence on the
resulting determination of the period of the signal, if
only the level occurs at a steep area of the curves.
However, because the choice of the criterion value
does influence the assessment of phase, DLMO times
were exclusively used for the estimation of the circa-
dian period (τ). All τ values approximated 24 h.
Between conditions, no significant differences in τval-
ues were found (Table 2).
Evaluation of the Sleep-Wake–Related and
Pacemaker-Related Temperature Components
Of the core body temperature data, 9.61% were
missing due to technical problems and matters of
hygiene. The analysis described earlier provided the
contributions of the circadian pacemaker and those of
the sleep-wake cycle to the raw temperature curves.
Figure 1 displays these contributions per condition.
The sleep-wake–induced temperature curve shows
a remarkable resemblance in the various conditions.
After waking up, body temperature shows a peak
induced by showering. Subsequently, it drops and
stays relatively stable during the remaining hours of
wakefulness. At the start of the 6.5-h period in bed, a
sharp decrease in temperature can be observed. The
mean level of body temperature (listed in Table 2) was
calculated by averaging the data of the last 6.5 h of
wakefulness and the 6.5 h of sleep. In this way, the
highly variable influence of showering on the mean
was excluded. Although not significantly, mean body
temperature of the patients was slightly higher during
the winter than during the summer and also slightly
higher than that of controls. The amplitudes of the
sleep-wake–induced variation of body temperature
(see Table 2) showed no differences between patients
and controls.
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Table 2. Circadian and sleep-wake–related characteristics derived from core body temperature and melatonin
Melatonin
Core Body Temperature
τa Meanb Sleep-Wake Amplitudec Circadian Amplituded Circadian Phasee
Patients (depressed; n = 7) 24.03 ± 0.07 37.23 ± 0.10 0.17 ± 0.020 0.14 ± 0.0097 4:31 ± 0:23
Patients (remitted; n = 7) 24.13 ± 0.08 37.22 ± 0.07 0.16 ± 0.021 0.12 ± 0.0060 4:26 ± 0:29
Patients (summer; n = 7) 24.17 ± 0.1 37.16 ± 0.11 0.15 ± 0.019 0.16 ± 0.0174 4:43 ± 0:27
Controls (winter; n = 7) 24.22 ± 0.08 37.00 ± 0.11 0.19 ± 0.024 0.17 ± 0.0150 5:12 ± 0:42
Controls (summer; n = 7) 24.27 ± 0.1 36.95 ± 0.15 0.17 ± 0.021 0.18 ± 0.0211 4:47 ± 0:22
Paired-samples t testf
Patient (depressed vs. remitted) 0.282 0.984 0.431 0.240 0.621
Patient (depressed vs. summer) 0.259 0.130 0.075 0.160 0.669
Patient (remitted vs. summer) 0.720 0.322 0.243 0.093 0.564
Patient (depressed) vs. control (winter) 0.129 0.163 0.473 0.050 0.481
Patient (remitted) vs. control (winter) 0.327 0.156 0.157 0.031 0.462
Patient (summer) vs. control (summer) 0.533 0.218 0.521 0.464 0.929
Control (winter) vs. control (summer) 0.563 0.726 0.408 0.634 0.464
a. The circadian rhythm period (τ) in hours (mean ± SEM) derived from the timing of the dim-light melatonin onset obtained on the first (day 4)
and the last (day 9) evening in time isolation.
b. Mean (± SEM) level of core body temperature (°C) calculated by averaging the temperature data of the last 6.5 h of wakefulness and the 6.5-h
sleeping period.
c. Amplitude (mean ± SEM) of the sleep-wake–related variation of body temperature (°C) defined as the standard deviation calculated over the
last 6.5 h of wakefulness and the 6.5-h sleeping period.
d. Amplitude (mean ± SEM) of the circadian variation of body temperature (°C) defined as the standard deviation calculated over the total cir-
cadian variation of body temperature.
e. Timing of the circadian temperature minimum (mean ± SEM) on the first morning in time isolation, determined by extrapolating backward
from the educed circadian pacemaker–related curves to the first day of the protocol.
f. p values obtained by two-tailed paired-samples t tests between the various conditions in which patients and controls participated.
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Figure 1 also shows the circadian variation of body
temperature plotted relative to the moment at which
the endogenous circadian temperature reaches its min-
imum. A measure of the amplitude of the pacemaker-
induced variation of body temperature is presented in
Table 2. Only comparisons of the depressed patients
and the remitted patients with the controls in winter
showed statistically significant differences (p = 0.050
and p = 0.031). The patients’ amplitude turned out to
be smaller. In each condition, the core body tempera-
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Figure 1. Sleep-wake–related and pacemaker-related variation of core body temperature obtained in a 120-h forced desynchrony experi-
ment. In each condition, 7 seasonal affective disorder (SAD) patients and 7 matched controls participated. The curves, plotted as deviation
from the mean, depict the mean (± SEM) temperature variation in each condition. The shaded area indicates the 6.5-h sleeping period
within the 20-h subjective day. Circadian time is defined here as the time from one minimum in the circadian component of core body tem-
perature to the next. This interval is divided into 24 equal circadian-hour intervals.
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ture curve reached its minimum in the early morning
(Table 2). Between conditions, no significant differ-
ences in the timing of this minimum were observed.
In Figure 2, a measure of the amplitude of the
pacemaker-induced temperature curve is plotted
against the average level of body temperature for all
subjects in all conditions. The data reveal a significant
correlation between the average level of body temper-
ature and the amplitude of the pacemaker-related
temperature component (Spearman rho = –0.627, p =
0.000). A significant correlation between these vari-
ables was also found in the patients and controls sepa-
rately (Spearman rho = –0.508 and –0.604, respectively,
p = 0.019 and p = 0.022). This suggests that the higher
the average level of body temperature, the smaller is
the amplitude of the endogenous circadian tempera-
ture component.
Polysomnography
The mean TSTs in the subjective nights in FD are
summarized in Figure 3. In the data of all conditions
combined, ANOVA with repeated measures yielded a
significant effect of night number in FD on TST, F(5,
26) = 6.872, p = 0.000. However, no significant interac-
tion between night number and condition was
detected, F(20, 116) = 0.667, p = 0.851. Separate
ANOVAs to compare the various conditions in which
patients and controls were studied did not reveal sig-
nificant differences either. Because night sequence
number is strictly linked to the circadian phase of the
respective sleep episode, the data show that TST var-
ies systematically as a function of circadian phase.
DISCUSSION
The aim of the present FD study was to compare the
characteristics of the endogenous circadian pace-
maker of SAD patients with those of matched controls.
It is concluded that the circadian pacemakers of
patients and controls have a similar period, in both
winter and summer and irrespective of the
























































Figure 2. Correlation between average level of core body temper-
ature and circadian amplitude. Shown is the standard deviation
(SD) of the circadian modulation (see Fig. 1, right panel) as a func-
tion of the average level of body temperature. The SD of the circa-
dian modulation is proportional to the circadian amplitude (for a
sine function, the SD equals ½√2 times the circadian amplitude).
Filled circles depict the data obtained in patients (n = 21), and
open circles depict data obtained in controls (n = 14). The diagonal
line represents the regression line. Correlation coefficient
(Spearman rho) of all conditions combined is –0.627 (p = 0.000), of
the patient group is –0.508 (p = 0.019), and of the control group is –
0.604 (p = 0.022).
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Figure 3. Duration of total sleep time as a function of the clock
time at midsleep. Filled circles represent patients while
depressed, open circles represent patients while remitted, and
filled triangles represent patients in summer. Open triangles rep-
resent controls in winter, and filled squares represent controls in
summer.
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symptomatological state of the patients. The same
applies to the phase of the endogenous circadian cycle
after 4 days of restricting sleep to the interval between
midnight and 0800. The only possible difference
detected in our study concerns the amplitude of the
endogenous circadian temperature component.
Compared to that found in controls, the circadian
amplitude appeared to be slightly smaller in SAD
patients in winter, both during a depressive episode
and in the recovered state.
Previously, we have reported on the circadian and
sleep-wake cycle–related variations of core body tem-
perature observed in one 54-year-old male SAD
patient studied in a 120-h FD protocol both while
depressed and while remitted after light therapy
(Koorengevel et al., 2000). This subject, who is
included in the present analysis, provided evidence
for a phase delay of the circadian pacemaker during a
depressive episode. This is in contrast with the
enlarged data set in which no evidence for pacemaker
disturbances in SAD was found. In addition, in the
present study DLMO values were used instead of
body temperature curves to estimate circadian period.
As expected on the basis of reduced sensitivity to
masking, the melatonin-derived τ values showed
much smaller standard deviations in comparison to
the temperature-derived values. This is the reason
that melatonin-derived τ values were used. In con-
trast, however, circadian phase was derived on the
basis of the body temperature curves. This was done
because melatonin-derived phase angles depend
strongly on the criterion melatonin concentration
value used to define DLMO. Data on the timing of the
offset of melatonin production are required in addi-
tion to onset data in order to determine the phase posi-
tion of the melatonin profile. In the absence of those
offset data, body temperature curves were used to
determine circadian phase.
Endogenous Circadian Period
DLMOs obtained in the first and last evening in
time isolation showed an endogenous circadian
period (τ) of approximately 24 h in each condition. Just
like body temperature, salivary and plasma melatonin
concentrations exhibit a distinct circadian rhythm.
Yet, apart from an endogenous circadian modulation,
the secretion of melatonin has also been found to
depend on the timing of the sleep-wake cycle (or the
dim light:dark cycle) (Gordijn et al., 1999; Ritz-
De Cecco et al., 1999; Wyatt et al., 1999). In the present
study, a small difference occurred in elapsed hours of
wakefulness on the 2 days of saliva collection. This
may have induced a small overestimation of τ in all
conditions. However, the τ values observed in SAD
patients and controls are similar to those computed
with temperature or melatonin data in other FD stud-
ies on healthy subjects in 20-h-day protocols (24.30 h,
Hiddinga et al., 1997; 24.1 to 24.2 h, Wyatt et al., 1999)
as well as in 28-h-day protocols (24.18 h, Czeisler et al.,
1999; 24.3 to 24.35 h, Carskadon et al., 1999). Such a
similarity between our results and those of longer-
lasting FD protocols further suggests that the duration
of the experiment has little influence on the results. So-
called aftereffects, by which a pacemaker would need
time to switch from its entrained 24-h state to its intrin-
sic free run, apparently are not very strong in humans.
The phase position of a circadian process during
entrainment depends on the intrinsic period length, a
long period leading to a late phase position. In the
absence of a difference in τ between SAD patients and
controls, the suggested phase delay of SAD (Lewy,
Sack, Singer, et al., 1987) cannot be attributed to a lon-
ger intrinsic period.
Circadian Phase
Unlike data from some treatment (Lewy, Sack,
Miller, et al., 1987; Sack et al., 1990; Lewy et al., 1998)
and constant routine (Dahl et al., 1993; Avery et al.,
1997) studies, our data did not show abnormalities of
circadian phase. No differences were found between
the various conditions with respect to the timing of the
circadian temperature minimum. Although this may
be due to the synchronizing effects of the instructions
concerning the timing of sleep on the days prior to FD,
it is also possible that the small sample size of the pres-
ent study is responsible. This will be discussed below.
Nevertheless, the data do not confirm a phase delay in
depressed SAD patients (Lewy, Sack, Singer, et al.,
1987). The implications of the present study for the
phase-shift hypothesis (i.e., whether a shift in phase of
the circadian pacemaker relative to the sleep-wake
cycle influences mood) will be discussed elsewhere
(Koorengevel et al., unpublished data).
Circadian Amplitude
In winter, a smaller endogenous circadian ampli-
tude was observed in depressed and remitted patients
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compared to controls. Average level of body tempera-
ture and circadian amplitude were negatively corre-
lated in the total data set as well as in the separate data
sets on patients and controls. Consequently, the rela-
tively small circadian amplitude in SAD patients
might be explained by the relatively high average
body temperature. Because body temperature in
homeothermic organisms is regulated within a
restricted range of values, it is conceivable that
because of ceiling effects, a higher body temperature
level leads to a smaller variation. Therefore, a decrease
of the endogenous circadian amplitude of body tem-
perature in depressed and remitted patients could be
the consequence of a higher level of body temperature
instead of the result of a disturbance of the circadian
system.
Influence of Menstrual Cycle
and NSAIDs on Body Temperature
To control for the influences of gender and for the
influences of gonadal hormones and oral contracep-
tives on body temperature specifically (Wright and
Badia, 1999), in each experiment female subjects were
studied in the same phase of the menstrual cycle
(which was the follicular phase if appropriate). Apart
from the sporadic use of NSAIDs by female patients in
all three conditions, all subjects were free of medica-
tion. Studies of the effects of NSAIDs on the body tem-
perature have been inconclusive. NSAIDs have been
reported to yield no effects on the circadian variation
of body temperature (Scales et al., 1988). However,
another study has observed an attenuation of the
decrease in tympanic temperature and a suppression
of melatonin secretion for some hours after nighttime
administration of an NSAID (Murphy et al., 1996).
Hence, small effects of the incidentally used NSAIDs
cannot be fully excluded.
Power of the Study
A disadvantage of the present study is the rather
small sample size. This is due to the high demands on
the subjects living in isolation from their normal envi-
ronment for such a long time. Small sample sizes have
consequences for the smallest detectable difference (δ)
(Sokal and Rohlf, 1981) of each variable under study. A
post hoc power analysis of the obtained results, under
the assumption of a power value of 0.8, revealed a
smallest detectable difference (δ) of (1) 0.45 °C in the
average core body temperature level, (2) 22 min in the
melatonin-derived τ values, (3) 0.059 °C in the ampli-
tude of the endogenous circadian temperature com-
ponent, and (4) 123 min in the timing of the circadian
temperature minimum. Thus, the absence of differ-
ences in phase position might be attributed to a lack of
power, whereas the obtained values for τ and ampli-
tude might be accurate enough to enable adequate
comparisons.
Another weakness of the present study is the rela-
tively large number of statistical tests performed,
which increases the chance of finding significant
results. Only the data on circadian amplitude yielded
statistically significant differences between SAD
patients (both when depressed and remitted) and con-
trols in winter. Although SAD patients might gener-
ally exhibit a smaller circadian amplitude in winter, it
is also possible that this result is due to chance varia-
tions in our sample. However, we have decided to per-
form multiple tests in order to avoid missing possible
differences in pacemaker characteristics between
patients and controls.
Clinical State
In all experiments, both patients and controls toler-
ated the protocol quite well. Comparison of the aver-
age scores on the BDI and SIGH-SAD-SR completed
prior to and directly following the 10-day protocol
revealed a small deterioration of mood in both
patients and controls. Thus, the FD protocol did not
induce a strong effect on mood in patients. In one FD
study, an interaction between pacemaker and sleep-
wake cycle–related variation was demonstrated in the
regulation of mood in healthy subjects (Boivin et al.,
1997). The present study revealed a similar modula-
tion of self-rated mood in the course of the experiment
in all conditions (Koorengevel et al., unpublished
data).
PSG data did show an effect of night sequence
number on TST. This effect did not differ between con-
ditions. Like the TST data from the present study, PSG
data obtained in another FD study using 20-h subjec-
tive days showed highest and lowest sleep efficiency
when sleep was centered on the minimum of core
body temperature and 16 h later, respectively (Wyatt
et al., 1999).
Thus, the 120-h FD protocol not only induced simi-
lar effects on sleep in patients and controls—it also
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hardly affected the overall clinical state. It can there-
fore be concluded that FD provides an adequate tool
in the study of the circadian system in depressed
patients.
In summary, this 120-h FD study on SAD suggests
that period and phase of the circadian pacemaker
assessed by measuring core body temperature and
melatonin do not differ in (1) depressed and remitted
SAD patients versus controls in winter, (2) in SAD
patients versus controls in summer, and (3) in SAD
patients and controls in winter versus summer. In
addition, the significant correlation between average
level of temperature and endogenous circadian ampli-
tude suggests that in SAD patients, thermoregulation
might be disturbed in the winter season.
ACKNOWLEDGMENTS
This research was supported by the Nederlandse
Gasunie B.V., the Medical Faculty of the University of
Groningen, the Academic Hospital Groningen, the
Ministry of Health, and the National Fund of Mental
Health. The authors are grateful to the subjects for
their participation; to Iteke te Riet, Ybe Meesters,
Gerda Bloem, Marijke Gordijn, Theodoor van Maaren,
Maarten Langenberg, Jan van Dijken, Marieke
Kienhuis, Wendy Blom, Louise Dols, and Jacqueline
Reisel for their contribution to the performance of the
study; to Camiel Elsinga for his help in scoring the
polysomnographical recordings; and to J.J. Veeken
and coworkers of the laboratory of the Hospital De
Gelderse Vallei for the melatonin analysis.
REFERENCES
American Psychiatric Association (1994) Diagnostic and Sta-
tistical Manual of Mental Disorders, 4th ed, Washington,
DC, American Psychiatric Press.
Aschoff J (1965) Circadian rhythms in man: A self-sustained
oscillator with a inherent frequency underlies human 24-
hour periodicity. Science 148:1427-1432.
Avery DH, Dahl K, Savage MV, Brengelmann GL, Larsen
LH, Kenny MA, et al (1997) Circadian temperature and
cortisol rhythms during a constant routine are phase-
delayed in hypersomnic winter depression. Biol Psychia-
try 41:1109-1123.
Bakker JO and Beersma DGM (1991) A digital 3-channel
recorder for long term registrations. Sleep Res 20A:485.
Beck AT, Rush AJ, Shaw BF, and Emergy G (1979) Cognitive
Therapy of Depression, New York, NY, John Wiley & Sons.
Boivin DB, Czeisler CA, Dijk DJ, Duffy JF, Folkard S, Minors
DS, et al (1997) Complex interaction of the sleep-wake
cycle and circadian phase modulates mood in healthy
subjects. Arch Gen Psychiatry 54:145-152.
Boivin DB, Duffy JF, Kronauer RE, and Czeisler CA (1996)
Dose-response relationships for resetting of human circa-
dian clock by light. Nature 379:540-542.
Brendel DH, Reynolds CF, Jennings JR, Hoch CC, Monk TH,
Berman SR, et al (1990) Sleep stage physiology, mood,
and vigilance responses to total sleep deprivation in
healthy 80-year-olds and 20-year-olds. Psycho-
physiology 27:677-685.
Carskadon MA, Labyak SE, Acebo C, and Seifer R (1999)
Intrinsic circadian period of adolescent humans mea-
sured in conditions of forced desynchrony. Neurosci Lett
260:129-132.
Checkley SA, Murphy DG, Abbas M, Marks M, Winton F,
Palazidou E, et al (1993) Melatonin rhythms in seasonal
affective disorder. Br J Psychiatry 163:332-337.
Czeisler CA, Allan JS, and Kronauer RE (1986) A method to
assess the intrinsic period of the endogenous circadian
oscillator. Sleep Res 15:266.
Czeisler CA, Brown EN, Ronda JM, Kronauer RE, Richard-
son GS, and Freitag WO (1985) Aclinical method to assess
the endogenous circadian phase (ECP) of the deep circa-
dian oscillator in man. Sleep Res 14:295.
Czeisler CA, Duffy JF, Shanahan TL, Brown EN, Mitchell JF,
Rimmer DW, et al (1999) Stability, precision, and near-24-
hour period of the human circadian pacemaker. Science
284:2177-2181.
Czeisler CA, Kronauer RE, Mooney JJ, Anderson JL, and
Allan JS (1987) Biologic rhythm disorders, depression,
and phototherapy: A new hypothesis. Psychiatric Clin
North Am 10:687-709.
Dahl K, Avery DH, Lewy AJ, Savage MV, Brengelmann GL,
Larsen LH, et al (1993) Dim light melatonin onset and cir-
cadian temperature during a constant routine in
hypersomnic winter depression. Acta Psychiatr Scand
88:60-66.
Dijk DJ, Duffy JN, and Czeisler CA (1992) Circadian and
sleep/wake dependent aspects of subjective alertness
and cognitive performance. J Sleep Res 1:112-117.
Eastman CI, Gallo LC, Lahmeyer HW, and Fogg LF (1993)
The circadian rhythm of temperature during light treat-
ment for winter depression. Biol Psychiatry 34:210-220.
Goldberg D and Williams PA (1988) User’s Guide to the Gen-
eral Health Questionnaire, Windsor, UK, NDER-Nelson.
Gordijn MC, Beersma DG, Korte HJ, and van den
Hoofdakker RH (1999) Effects of light exposure and sleep
displacement on dim light melatonin onset. J Sleep Res
8:163-174.
Graw P, Haug HJ, Leonardt G, and Wirz-Justice A (1998)
Sleep deprivation response in seasonal affective disorder
during a 40-h constant routine. J Affective Disord 48:69-
74.
Hiddinga AE, Beersma DG, and van den Hoofdakker RH
(1997) Endogenous and exogenous components in the
circadian variation of core body temperature in humans.
J Sleep Res 6:156-163.
Honma K and Honma S (1988) A human phase response
curve for bright light pulses. Jpn J Psychiatry Neurol
42:167-168.
474 JOURNAL OF BIOLOGICAL RHYTHMS / October 2002
 at University of Groningen on August 26, 2009 http://jbr.sagepub.comDownloaded from 
Horne JA and Ostberg O (1976) A self-assessment question-
naire to determine morningness-eveningness in human
circadian rhythms. Int J Chronobiol 4:97-110.
Jewett ME, Rimmer DW, Duffy JF, Klerman EB, Kronauer
RE, and Czeisler CA (1997) Human circadian pacemaker
is sensitive to light throughout subjective day without
evidence of transients. Am J Physiol 273:R1800-R1809.
Kasper S, Wehr TA, Bartko JJ, Gaist PA, and Rosenthal NE
(1989) Epidemiological findings of seasonal changes in
mood and behavior: A telephone survey of Montgomery
County, Maryland. Arch Gen Psychiatry 46:823-833.
Kleitman N and Kleitman E (1953) Effect of non-twenty-
four-hour routines of living on oral temperature and
heart rate. J Appl Physiol 6:283-291.
Koorengevel KM, Beersma DGM, Gordijn MCM, den Boer
JA, and van den Hoofdakker RH (2000) Body tempera-
ture and mood variations during forced desynchron-
ization in winter depression: A preliminary report. Biol
Psychiatry 47:355-358.
Levendosky AA, Joseph-Vanderpool JR, Hardin T, Sorek E,
and Rosenthal NE (1991) Core body temperature in
patients with seasonal affective disorder and normal con-
trols in summer and winter. Biol Psychiatry 29:524-534.
Lewy AJ, Bauer VK, Cutler NL, Sack RL, Ahmed S, Thomas
KH, et al (1998) Morning vs evening light treatment of
patients with winter depression. Arch Gen Psychiatry
55:890-896.
Lewy AJ, Sack RL, Miller LS, and Hoban TM (1987) Antide-
pressant and circadian phase-shifting effects of light. Sci-
ence 235:352-354.
Lewy AJ, Sack RL, and Singer CM (1985) Immediate and
delayed effects of bright light on human melatonin pro-
duction: Shifting “dawn” and “dusk” shifts the dim light
melatonin onset (DLMO). Ann N Y Acad Sci 453:253-259.
Lewy AJ, Sack RL, Singer CM, and White DM (1987) The
phase shift hypothesis for bright light’s therapeutic
mechanism of action: Theoretical considerations and
experimental evidence. Psychopharmacol Bull 23:349-
353.
Lewy AJ, Wehr TA, Goodwin FK, Newsome DA, and
Markey SP (1980) Light suppresses melatonin secretion
in humans. Science 210:1267-1269.
Mills JN, Minors DS, and Waterhouse JM (1978) Adaptation
to abrupt time shifts of the oscillator(s) controlling
human circadian rhythms. J Physiol 285:455-470.
Minors DS, Waterhouse JM, and Wirz-Justice A (1991) A
human phase-response curve to light. Neurosci Lett
133:36-40.
Murphy PJ, Myers BL, and Badia P (1996) Nonsteroidal anti-
inflammatory drugs alter body temperature and sup-
press melatonin in humans. Physiol Behav 59:133-139.
Rechtschaffen A and Kales A (1968) A Manual of Standardized
Terminology, Techniques, and Scoring System for Sleep Stages
of Human Subjects, Washington, DC, Government Print-
ing Office.
Ritz-De Cecco A, Jewett ME, Wyatt JK, Kronauer RE,
Czeisler CA, and Dijk DJ (1999) Plasma melatonin
rhythm in humans during a 20-h forced desynchrony
protocol. Sleep Res Online 2(suppl 1):620.
Rosenthal NE, Genhart M, Sack DA, Skwerer RG, and Wehr
TA(1987) Seasonal affective disorder and its relevance for
the understanding and treatment of bulimia. In The Psy-
chology of Bulimia, JJ Hudson and HG Pope Jr, eds, pp 205-
228, Washington, DC, American Psychiatric Press.
Rosenthal NE, Levendosky AA, Skwerer RG, Joseph-
Vanderpool JR, Kelly KA, Hardin T, et al (1990) Effects of
light treatment on core body temperature in seasonal
affective disorder. Biol Psychiatry 27:39-50.
Rosenthal NE, Sack DA, Gillin JC, Lewy AJ, Goodwin FK,
Davenport Y, Mueller PS, et al (1984) Seasonal affective
disorder: A description of the syndrome and preliminary
findings with light therapy. Arch Gen Psychiatry 41:72-
80.
Sack RL, Lewy AJ, White DM, Singer CM, Fireman MJ, and
Vandiver R (1990) Morning vs evening light treatment for
winter depression: Evidence that the therapeutic effects
of light are mediated by circadian phase shifts. Arch Gen
Psychiatry 47:343-351.
Scales WE, Vander AJ, Brown MB, and Kluger MJ (1988)
Human circadian rhythms in temperature, trace metals,
and blood variables. J Appl Physiol 65:1840-1846.
Schwartz PJ, Rosenthal NE, Turner EH, Drake CL, Liberty V,
and Wehr TA (1997) Seasonal variation in core tempera-
ture regulation during sleep in patients with winter sea-
sonal affective disorder. Biol Psychiatry 42:122-131.
Sokal RR and Rohlf IJ (1981) Biometry: The Principles and Prac-
tice of Statistics in Biological Research, 2nd ed, New York,
NY, WH Freeman and Company.
Terman JS, Terman M, Lo ES, and Cooper TB (2001) Circa-
dian time of morning light administration and therapeu-
tic response in winter depression. Arch Gen Psychiatry
58:69-75.
Thompson C, Childs PA, Martin NJ, Rodin I, and Smythe PJ
(1997) Effects of morning phototherapy on circadian
markers in seasonal affective disorder. Br J Psychiatry
170:431-435.
Van Esseveldt KE, Lehman MN, and Boer GJ (2000) The
suprachiasmatic nucleus and the circadian time-keeping
system revisited. Brain Res Rev 33:34-77.
Williams JBW, Link MJ, Rosenthal NE, Amira L, and Terman
M (1992) Structured Interview Guide for the Hamilton Rating
Scale–Seasonal Affective Disorder Version (SIGH-SAD,
SIGH-SAD-SR, Self-Rating Version), New York, NY, New
York State Psychiatric Institute.
Wirz-Justice A, Kräuchi K, Brunner DP, Graw P, Haug HJ,
Leonardt G, et al (1995) Circadian rhythms and sleep reg-
ulation in seasonal affective disorder. Acta Neuropsychi-
atrica 7:41-43.
Wright KP and Badia P (1999) Effects of menstrual cycle
phase and oral contraceptives on alertness, cognitive per-
formance, and circadian rhythms during sleep depriva-
tion. Behav Brain Res 103:185-194.
Wyatt JK, Cecco AR, Czeisler CA, and Dijk DJ (1999) Circa-
dian temperature and melatonin rhythms, sleep, and
neurobehavioral function in humans living on a 20-h day.
Am J Physiol 277:R1152-R1163.
Koorengevel et al. / FORCED DESYNCHRONY IN SAD 475
 at University of Groningen on August 26, 2009 http://jbr.sagepub.comDownloaded from 
